INSERM U1183
Director of the research unit UMR1183
UPDATE ON MSC BASED THERAPY IN RHEUMATIC DISEASES
October 14th
From the beginning of my career in 2001 at the “Etablissement Français du Sang” (EFS, BFC, Besançon), I became interested in translational research and more particularly to modulate the T cells lymphocyte response, such as T cells involved in host-graft-tumor...
En savoir +Pharmacien et ancien interne des hôpitaux de Paris, Anne Fialaire-Legendre a été nommée à l’Agence Française du Sang en 2003 pour participer activement à la réforme de la transfusion sanguine. Elle est à l’origine de la création du réseau français...
En savoir +Dr. Emmanuel Donnadieu leads the team ‘Cancer and immune response’ at the Cochin Institute, INSERM, in Paris. Working in the field of Immunology for more than 15 years, he has accumulated a thorough experience in cell signalling and cellular imaging...
En savoir +Doctor in Immunology, researcher at and former director of the Autoimmunity-Transplantation-Inflammation research team at the INSERM-Univ Franche Comté-EFS Joint Research Unit 1098 RIGHT in Besançon (FR) for the last 10 years, Dr Perruche is now the founder and CEO of...
En savoir +Mathieu Guerriaud is a Doctor of Pharmacy (PharmD) and a Doctor of Science (PhD). He is an associate professor in pharmaceutical law, teaching at the Faculty of Health Sciences while working as a researcher in a law laboratory: the CREDIMI....
En savoir +Christian Chabannon is the Qualified Person for the Centre de Thérapie Cellulaire that associates the Cell Collection Facility and the Cell Processing Facility at Institut Paoli-Calmettes Comprehensive Cancer Center, in Marseille, France.
En savoir +- 1968 : Thèse de Médecine, Paris - 1970 ; Certificat d’Etudes Spéciales en Hématologie - 1970- 1974 : Assistant bi-appartenant, Hôpitaux de Paris/Université Paris VII, UER d’Hématologie - 1974-1978 :Chef de Service –adjoint, Service d’Immuno-Hématologie, Hôpital Lariboisière-AP/HP, Paris -...
En savoir +Marcello Maresca is an Associate Director at AstraZeneca where he is currently leading the Precise Genome Editing team. In his role he supervises the strategy for the generation of advanced cellular and animal models of disease and for Therapeutic Genome...
En savoir +Experienced Professor with a demonstrated history of working in the higher education industry. Skilled in Regenerative Medicine, Molecular Oncology, Hematology, Biotechnology, and Stem Cells. Strong healthcare services professional graduated from University Paris Descartes - School of Medicine.
En savoir +Marie José Stasia is an Associate professor (Pharm D, PhD) at the University Grenoble Alpes and an hospital partitionner in charge of the unique national referent laboratory for the Chronic Granulomatous Disease (CGD) diagnostic (phenotype and genotype) at the Centre...
En savoir +After an initial training in clinical hematology, I worked in an hematology intensive care and bone transplantation unit, then as a clinical consultant at the Besançon University hospital, France until 2009. I headed an immunogenetics laboratory from 1994 to 2004...
En savoir +Hanover Medical School Clinic for Paediatric Pneumology, Allergology and Neonatology
En savoir +Holding a PhD in Oncology and a MBA in Biotech Management, Camille has been working in the field of cell and gene therapy for the past 5 years. She successively worked for Merck Millipore, Pfizer and Miltenyi Biotec before joining...
En savoir +John De Vos is Professor of Embryology, Histology and Regenerative Medicine at the Faculty of Medicine of Montpellier, and head of the Cellular and Tissue Engineering Department of the University Hospital Center (CHU) of Montpellier. His research, at the Research...
En savoir +Prof. Stéphane Depil, M.D., Ph.D., is onco-hematologist at Léon Bérard Cancer Center, group leader at Cancer Research Center of Lyon, and adjunct Professor at University Claude Bernard Lyon 1, France. He was also Visiting Professor at King’s College London. He...
En savoir +Jordan Gauthier is an Assistant Professor at the Fred Hutchinson Cancer Research Center (FHCRC) and the University of Washington in Seattle, WA. He was the first physician to be awarded the FHCRC Immunotherapy Integrated Research Center Fellowship Award. An expert...
En savoir +Nicolas Ferry is a M.D., Ph.D. His initial training in research was in endocrinology and pharmacology where he studies the regulation alpha adrenergic receptors in liver and blood platelets. During a post-doctoral stay at the Pasteur Institute in 1990, he...
En savoir +I studied Pharmacy in Tuebingen, did my PhD in Immunology, joined Miltenyi in 2003. There I started in the R&D Department, then changed to the Clinical Development department and now I´m Group Leader for T cell Immunotherapy in the Miltenyi...
En savoir +